Cipla acquires US-based Avenue Therapeutics for $215 million News News / News 5 years ago 412 Views comments The acquisition will give Cipla access to specialty drug Tramadol delivered intravenously (IV) to manage post-operative pain. Read more
News Bofors payoff case: Supreme Court to commence final hearing in last week of October News / News - 6 years ago
News Growing question mark on maritime security, nukes: Sushma Swaraj at UNGA News / News - 6 years ago
News The Rohingya#39;s plight: A history of the #39;floating population#39; in Myanmar News / News - 6 years ago
Comments